Company Biotoxtech Co., Ltd.

Equities

A086040

KR7086040003

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per region

Sector Other Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 23:00:00 29/04/2024 BST			5-day change	1st Jan Change
5,600 ^KRW	-0.88%		+3.90%	-9.09%

2022	Biotoxtech Co., Ltd.(KOSDAQ:A086040) dropped from S&P Global BMI Index	CI
2021	Biotoxtech Co., Ltd.(KOSDAQ:A086040) added to S&P Global BMI Index	CI

Biotoxtech Co., Ltd. is a Korea-based company engaged in the research of non-clinical evaluation business. The Company provides safety evaluation research, efficacy evaluation research and analysis research. Its safety evaluation research business provides general toxicity tests, local toxicity tests, reproductive and development tests, genotoxicity tests, immunotoxicity tests, carcinogenicity tests, safety pharmacology tests, ecotoxicology tests, histopathology tests and hematology tests. Its efficacy evaluation research business provides efficacy evaluation of medical supplies, health supplements and cosmetics. Its analysis research business provides pharmacokinetics (PK) tests and toxicokinetics (TK) tests services, as well as validation and bio analysis services. On March 13, 2013, the Company acquired a 60% stake in its new established subsidiary.

Number of employees: 221

KRW in Million	2022	Weight	2023	Weight	Delta
Research and Development Service 100.0 %	37,292	100.0 %	32,631	100.0 %	-12.50%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 92.6 %	36,040	96.6 %	30,224	92.6 %	-16.14%
Overseas 7.4 %	1,252	3.4 %	2,407	7.4 %	+92.24%

Managers	Title	Age	Since
Jong-Gu Kang CEO	Chief Executive Officer	68	31/12/99
Seok-Mo Kang CTO	Chief Tech/Sci/R&D Officer	39	-
Soo-Yong Jeong BRD	Director/Board Member	51	-
Cheol-Beom Park BRD	Director/Board Member	61	-
Dong-Il Kim BRD	Director/Board Member	56	-
Won-Bae Kim AUD	Comptroller/Controller/Auditor	51	-

Members of the board	Title	Age	Since
Jong-Gu Kang CEO	Chief Executive Officer	68	31/12/99
Dong-Il Kim BRD	Director/Board Member	56	-
Cheol-Beom Park BRD	Director/Board Member	61	-
Soo-Yong Jeong BRD	Director/Board Member	51	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	15,958,248	10,768,603 ( 67.48 %)	30,735 ( 0.1926 %)	67.48 %
Stock B	0	1	0	0

Name	Equities	%	Valuation
Jong-Gu Kang 12.76 %	2,035,965	12.76 %	9 M ₩
CELLTRION, INC. 10.22 %	1,631,134	10.22 %	7 M ₩
Keyfron Bio Co., Ltd. 7.558 %	1,206,159	7.558 %	5 M ₩
Suk-chun Yoon 0.9901 %	158,000	0.9901 %	704 178 ₩
Gyeong-ae Kang 0.3233 %	51,599	0.3233 %	229 967 ₩
BIOTOXTECH CO., LTD. 0.1926 %	30,735	0.1926 %	136 980 ₩
Myeong-jeong Lee 0.1567 %	25,000	0.1567 %	111 421 ₩
Dong-Il Kim 0.1011 %	16,128	0.1011 %	71 880 ₩
Cheol-Beom Park 0.0376 %	6,000	0.0376 %	26 741 ₩
DFA Australia Ltd. 0.008547 %	1,364	0.008547 %	6 079 ₩

Name	Equities	%	Valuation
BIOTOXTECH CO., LTD. 0.19%	30,735	0.19%	136,980 $

Biotoxtech Co., Ltd.

Ochang Science Industrial Complex 53 Yeongudanji-ro, Ochang-eup

28115, Cheongju-si

http://www.biotoxtech.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
BIOTOXTECH CO., LTD.	-9.09%	65.42M
IQVIA HOLDINGS INC.	+0.17%	42.86B
MODERNA, INC.	+10.92%	42.74B
LONZA GROUP AG	+44.30%	41.36B
CELLTRION, INC.	-6.20%	27.68B
ICON PUBLIC LIMITED COMPANY	+5.23%	25.15B
ALNYLAM PHARMACEUTICALS, INC.	-24.79%	18.63B
MEDPACE HOLDINGS, INC.	+26.69%	12.37B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.13%	11.92B
UNITED THERAPEUTICS CORPORATION	+6.57%	11.21B

Other Biotechnology & Medical Research